These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12663461)

  • 1. Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.
    Woerle HJ; Mariuz PR; Meyer C; Reichman RC; Popa EM; Dostou JM; Welle SL; Gerich JE
    Diabetes; 2003 Apr; 52(4):918-25. PubMed ID: 12663461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.
    Bitnun A; Sochett E; Babyn P; Holowka S; Stephens D; Read S; King SM
    AIDS; 2003 Jun; 17(9):1319-27. PubMed ID: 12799553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
    Tebas P; Yarasheski K; Henry K; Claxton S; Kane E; Bordenave B; Klebert M; Powderly WG
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):589-94. PubMed ID: 15242534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
    Behrens G; Dejam A; Schmidt H; Balks HJ; Brabant G; Körner T; Stoll M; Schmidt RE
    AIDS; 1999 Jul; 13(10):F63-70. PubMed ID: 10416516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.
    Haugaard SB; Andersen O; Dela F; Holst JJ; Storgaard H; Fenger M; Iversen J; Madsbad S
    Eur J Endocrinol; 2005 Jan; 152(1):103-12. PubMed ID: 15762193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.
    Reeds DN; Yarasheski KE; Fontana L; Cade WT; Laciny E; DeMoss A; Patterson BW; Powderly WG; Klein S
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E47-E53. PubMed ID: 16118251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.
    Bitnun A; Sochett E; Dick PT; To T; Jefferies C; Babyn P; Forbes J; Read S; King SM
    J Clin Endocrinol Metab; 2005 Jan; 90(1):168-74. PubMed ID: 15483082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.
    van der Valk M; Bisschop PH; Romijn JA; Ackermans MT; Lange JM; Endert E; Reiss P; Sauerwein HP
    AIDS; 2001 Nov; 15(16):2093-100. PubMed ID: 11684928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
    Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
    Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in hypertension is associated with body fat rather than blood pressure.
    Toft I; Bønaa KH; Jenssen T
    Hypertension; 1998 Jul; 32(1):115-22. PubMed ID: 9674647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
    Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
    Haugaard SB; Andersen O; Storgaard H; Dela F; Holst JJ; Iversen J; Nielsen JO; Madsbad S
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E677-85. PubMed ID: 15149949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
    Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic effects of lopinavir/ritonavir in HIV-negative men.
    Lee GA; Seneviratne T; Noor MA; Lo JC; Schwarz JM; Aweeka FT; Mulligan K; Schambelan M; Grunfeld C
    AIDS; 2004 Mar; 18(4):641-9. PubMed ID: 15090769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in HIV protease inhibitor-associated diabetes.
    Yarasheski KE; Tebas P; Sigmund C; Dagogo-Jack S; Bohrer A; Turk J; Halban PA; Cryer PE; Powderly WG
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):209-16. PubMed ID: 10421244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.
    Enoksson S; Caprio SK; Rife F; Shulman GI; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1503-11. PubMed ID: 12679430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.